WELDON LLOYD

449 total citations
18 papers, 357 citations indexed

About

WELDON LLOYD is a scholar working on Oncology, Nephrology and Molecular Biology. According to data from OpenAlex, WELDON LLOYD has authored 18 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Nephrology and 3 papers in Molecular Biology. Recurrent topics in WELDON LLOYD's work include Bone health and treatments (10 papers), Parathyroid Disorders and Treatments (4 papers) and Bone and Dental Protein Studies (3 papers). WELDON LLOYD is often cited by papers focused on Bone health and treatments (10 papers), Parathyroid Disorders and Treatments (4 papers) and Bone and Dental Protein Studies (3 papers). WELDON LLOYD collaborates with scholars based in United States, Switzerland and Myanmar. WELDON LLOYD's co-authors include Herbert Wells, William J. Ryan, A H Tashjian, Edward F. Voelkel, Rik Derynck, Lawrence Levine, Marjorie E. Winkler, Richard B. Nimberg, Karl Schmid and Ramesh Narang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

WELDON LLOYD

17 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
WELDON LLOYD United States 11 165 134 54 54 38 18 357
Tashjian Ah United States 10 127 0.8× 162 1.2× 113 2.1× 34 0.6× 62 1.6× 14 495
David R. Healy United States 9 153 0.9× 91 0.7× 83 1.5× 29 0.5× 38 1.0× 11 343
Socorro J. Vargas United States 9 168 1.0× 219 1.6× 16 0.3× 25 0.5× 43 1.1× 11 355
Yoshiharu Hiruma Japan 11 238 1.4× 127 0.9× 23 0.4× 65 1.2× 22 0.6× 15 435
L. Lammers Germany 5 66 0.4× 45 0.3× 37 0.7× 209 3.9× 55 1.4× 8 324
Indira V. Kurup United States 10 84 0.5× 47 0.4× 16 0.3× 135 2.5× 51 1.3× 12 374
Martine Bisson Canada 13 264 1.6× 155 1.2× 24 0.4× 51 0.9× 23 0.6× 15 430
S Pun United States 12 237 1.4× 174 1.3× 12 0.2× 29 0.5× 60 1.6× 15 439
H Liang United States 10 185 1.1× 151 1.1× 11 0.2× 21 0.4× 45 1.2× 11 360
Shin-Long Wu Taiwan 8 305 1.8× 53 0.4× 28 0.5× 74 1.4× 40 1.1× 10 476

Countries citing papers authored by WELDON LLOYD

Since Specialization
Citations

This map shows the geographic impact of WELDON LLOYD's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by WELDON LLOYD with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites WELDON LLOYD more than expected).

Fields of papers citing papers by WELDON LLOYD

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by WELDON LLOYD. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by WELDON LLOYD. The network helps show where WELDON LLOYD may publish in the future.

Co-authorship network of co-authors of WELDON LLOYD

This figure shows the co-authorship network connecting the top 25 collaborators of WELDON LLOYD. A scholar is included among the top collaborators of WELDON LLOYD based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with WELDON LLOYD. WELDON LLOYD is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
LLOYD, WELDON, M.S. Lamkin, Wayne A. Gonnerman, et al.. (1988). Human Serumα2HS-Glycoprotein Modulatesin VitroBone Resorption*. The Journal of Clinical Endocrinology & Metabolism. 66(1). 187–192. 43 indexed citations
2.
Lamkin, M.S., Mary L. Rodrick, Robert F. Troxler, et al.. (1987). Three forms of BRP-2 (bone resorptive proteins) from human cancer ascites fluid and their relationship to human serum alpha-2 HS-glycoprotein. Calcified Tissue International. 41(3). 171–175. 13 indexed citations
3.
Lamkin, M.S., et al.. (1986). Purification and partial characterization of a Mr 52,000 glycoprotein from human cancer ascites fluid which stimulates bone resorption in vitro.. PubMed. 46(9). 4650–5. 3 indexed citations
4.
Tashjian, A H, Edward F. Voelkel, WELDON LLOYD, et al.. (1986). Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice.. Journal of Clinical Investigation. 78(5). 1405–1409. 75 indexed citations
5.
Nimberg, Richard B., Donald E. Humphries, WELDON LLOYD, Herbert Wells, & Karl Schmid. (1982). Purification and partial characterization of a protein from cancer ascites fluid which stimulates the resorption of bone explants in vitro.. Journal of Biological Chemistry. 257(5). 2477–2482. 7 indexed citations
6.
Dziak, Rosemary, Donald E. Humphries, WELDON LLOYD, et al.. (1980). Effects of a bone resorptive factor from human cancer ascites fluid on rat bone cell calcium and cyclic AMP. Calcified Tissue International. 30(1). 191–197. 7 indexed citations
7.
Nimberg, Richard B., Donald E. Humphries, WELDON LLOYD, et al.. (1978). Isolation of a bone-resorptive factor from human cancer ascites fluid.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(7). 1983–9. 14 indexed citations
8.
Wells, Herbert, et al.. (1976). Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells. Prostaglandins. 12(4). 501–513. 54 indexed citations
9.
LLOYD, WELDON, Herbert Wells, Marlin W. Walling, & Daniel V. Kimberg. (1975). Stimulation of Bone Resorption in Organ Culture by Salt-Free Extracts of Solanum Glaucophyllum. Endocrine Research Communications. 2(2). 159–166. 7 indexed citations
10.
LLOYD, WELDON, et al.. (1975). Thiophene Compounds that Reduce Calculus Accumulation and Inhibit Bone Resorption. Journal of Dental Research. 54(2_suppl). 87–87. 2 indexed citations
11.
Narang, Ramesh, Herbert Wells, & WELDON LLOYD. (1973). Demineralization of bone transplants in vivo. Oral Surgery Oral Medicine Oral Pathology. 36(2). 291–304. 7 indexed citations
12.
Narang, Ramesh, WELDON LLOYD, & Herbert Wells. (1971). Grafts of Decalcified Allogeneic Bone Matrix Promote the Healing of Fibular Fracture Gaps in Rats. Clinical Orthopaedics and Related Research. 80. 174–180. 20 indexed citations
13.
Wells, Herbert & WELDON LLOYD. (1970). Cyclic 3',5'-adenylic acid in bone and the mechanism of action of parathyroid hormone. Discussion.. PubMed. 29(3). 1183–4. 1 indexed citations
14.
LLOYD, WELDON, Victor S. Fang, Herbert Wells, & Armen H. Tashjian. (1969). 2-Thiophenecarboxylic Acid: A Hypoglycemic, Antilipolytic Agent with Hypocalcemic and Hypophosphatemic Effects in Rats. Endocrinology. 85(4). 763–768. 15 indexed citations
15.
Wells, Herbert, et al.. (1969). Hypercalcemic and Hypophosphatemic Effects of Dibutyryl Cyclic AMP in Rats After Parathyroidectomy. Endocrinology. 84(4). 861–867. 25 indexed citations
16.
Wells, Herbert & WELDON LLOYD. (1968). Inhibition of the Hypocalcemic Action of Thyrocalcitonin by Theophylline and Isoproterenol. Endocrinology. 82(3). 468–474. 15 indexed citations
17.
Wells, Herbert & WELDON LLOYD. (1968). Hypocalcemic Effect of Imidazole in Rats. Endocrinology. 83(3). 521–529. 24 indexed citations
18.
Wells, Herbert & WELDON LLOYD. (1967). Effects of Theophylline on the Serum Calcium of Rats After Parathyroidectomy and Administration of Parathyroid Hormone. Endocrinology. 81(1). 139–144. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tashjian Ah Breakdown of academic impact, for papers by David R. Healy Breakdown of academic impact, for papers by Socorro J. Vargas Breakdown of academic impact, for papers by Yoshiharu Hiruma Breakdown of academic impact, for papers by L. Lammers Breakdown of academic impact, for papers by Indira V. Kurup Breakdown of academic impact, for papers by Martine Bisson Breakdown of academic impact, for papers by S Pun Breakdown of academic impact, for papers by H Liang Breakdown of academic impact, for papers by Shin-Long Wu
Rankless by CCL
2026